SPEAKERS

ALL SPEAKERS

Craig Burton

Senior Vice President, Policy and Strategic Alliances, AAM
Executive Director, Biosimilars Council

Keren Haruvi

Board Chair
Association for Accessible Medicines (AAM)

Iilun Murphy, M.D.

Director
Office of Generic Drugs (OGD), CDER FDA

Jacqueline Corrigan-Curray, JD, M.D.

Principal Deputy Center Director
Center for Drug Evaluation and Research (CDER), FDA

David Gaugh, RPh

Interim President & CEO
AAM

Scott Kuzner, PhD

Senior Director, Sciences and Regulatory Affairs
AAM

Elizabeth Miller, PharmD

Assistant Commissioner For Medical Products and Tobacco Operations, Office of Regulatory Affairs (ORA)
FDA

Giuseppe Randazzo

Senior Vice President, Sciences and Regulatory Affairs
AAM

Janet Woodcock, M.D.

Former Principal Deputy Commissioner, FDA

Sarah Yim, M.D.

Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs (OND), CDER
FDA